17-β Estradiol Preserves Endothelial Cell Viability in an In Vitro Model of Homocysteine-Induced Oxidative Stress
- 1 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 39 (3) , 347-353
- https://doi.org/10.1097/00005344-200203000-00005
Abstract
High levels of homocysteine (Hcy) accelerate endothelial cell damage by producing hydrogen peroxide (H2O2). We investigated whether 17-β estradiol may prevent the accelerated rate of endothelial cell detachment and reduced cell viability in cultured endothelial cells challenged with Hcy. Cultured bovine aortic endothelial cells (BAEC) were incubated for 72-h with either vehicle (alcohol) or different concentrations of 17-β estradiol (1 nM [1E2] and 10 nM [10E2]) before being challenged with 0.5 mM of Hcy. Cell viability and H2O2 levels were evaluated at 30 min, 1-, 2-, 4-, 8-, and 24-h after adding Hcy. Cell suspensions were frozen in liquid nitrogen and used later for spectrophotometric measurement of intracellular glutathione (GSH) levels. Cell viability 24 h after Hcy administration was significantly lower in vehicle versus 1 nM and 10 nM 17-β estradiol (44 ± 5% vs. 70.66 ± 4%, [p < 0.001] and 79 ± 5% respectively, [p < 0.001]). H2O2 levels were higher in vehicle (1 ± 0.05 μM) compared with 1E2 and 10E2 (0.8 ± 0.1 μM, p = 0.02 and 0.1 ± 0.05 μM, respectively, p < 0.001), whereas GSH content was increased in 1E1 and 10E2 versus control (27.69 ± 4.6 nM/106 cells and 43.49 ± 5.5 nM/106 cells vs. 13.33 ± 1.5 nM/106 cells, p < 0.001). Bovine aortic endothelial cells treatment with 17-β estradiol (0, 1, and 10 nM) and 0.1 mmol buthionine sulfoximine, an inhibitor of gamma-glutamylcysteine synthase, abolished the beneficial effects of estradiol alone on cell viability, GSH content, and H2O2 generation. Estradiol prevents Hcy-induced endothelial cell injury by increasing the intracellular content of GSH.Keywords
This publication has 19 references indexed in Scilit:
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Mechanisms of 17 β‐oestradiol induced vasodilatation in isolated pressurized rat small arteriesBritish Journal of Pharmacology, 2000
- 17-β Estradiol Regulation of Myocardial Glutathione and Its Role in Protection Against Myocardial Stunning in DogsJournal of Cardiovascular Pharmacology, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- The oxidant stress of hyperhomocyst(e)inemia.Journal of Clinical Investigation, 1996
- Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Homocysteine metabolism and the oxidative modification of proteins and lipidsFree Radical Biology & Medicine, 1993
- Biochemistry of Nitric Oxide and Its Redox-Activated FormsScience, 1992
- Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.Journal of Clinical Investigation, 1986
- Selective Modification of Glutathione MetabolismScience, 1983